Alnylam Pharmaceuticals (ALNY) Q4 2016 Earnings

2NovConfirmed
Q1 2016
Q2 2016
Q3 2016
Q4 2016
-1.25
-1.15
-1.06
-0.96

Details

Expected EPS
-1.13
Actual EPS
-1.21
Surprise EPS
-0.08
Surprise Percent
+7.08%

Description

Alnylam Pharmaceuticals (ALNY) has reported earnings of -1.21 per share for Q4 2016.

0 Comments

Share your thoughts